Introduction
Extracellular matrix (ECM) remodeling is a key process in the development of heart failure following sustained periods of pressure overload. Cardiac fibroblasts are the main producers and regulators of ECM and are therefore important for maintaining the correct passive tension and elastic properties of the myocardium. In the pressure-overloaded heart, fibroblasts experience increased mechanical stress and start producing excessive amounts of ECM which may ultimately lead to fibrosis and reduced diastolic compliance [1] . These activated fibroblasts also acquire contractile features enabling them to "pull" on the ECM and thereby increase matrix tension. Hence, they are smooth muscle cell-like in terms of expressing markers defining smooth muscle cells, such as smooth muscle α-actin (SMA) [2] and SM22, but at the same time retain typical fibroblast features such as the ability to produce large amounts of ECM. Cells with this phenotype are therefore referred to as myofibroblasts. Even though, the fibroblast-myofibroblast phenotypes reflect a continuum of functional statuses and not one single cell type, we will throughout the paper use the term myofibroblast differentiation for the process involving up-regulation of ECM genes and de novo expression and organization of SMA fibers in cardiac fibroblasts. Originally described in the granulation tissue of skin wounds, differentiation of relatively quiescent fibroblasts to a more proliferative and contractile cell, the myofibroblasts, was found to be a necessary step in wound healing as myofibroblasts contribute to mechanical stability of the wound by forming a scar.
Mechanical stress and several signaling molecules have been found to induce myofibroblast differentiation, the most well-known being TGFβ [3] . It has also been established that mechanical stress induces the differentiation of cardiac fibroblasts into myofibroblasts [4] . However, the underlying mechanisms are largely unknown.
The existence of mechanosensing molecules in the plasma membrane of cardiac cells has long been subject to great interest. Such a mechanosensor is likely attached to the ECM as well as to the cytoskeleton intracellularly where it also interacts with downstream signaling molecules. One protein that has received considerable attention lately is syndecan-4 [5] due to its localization in focal adhesions which are the contact points between the cell surface and ECM, and recognized sites of mechanotransduction and mechanosensing [6, 7] . Similarly to integrins, syndecan-4 binds to fibronectin and collagens via its glucosaminoglycan (GAG) chains and interact, either alone or in concert with integrins, with several intracellular signaling molecules such as focal adhesion kinase (FAK), phosphatidylinositol 4,5-biphosphate (PIP2), PKCα, CASK and RhoA [8] . These interactions are important for the assembly of focal adhesions, cell attachment and spreading [9] . Whereas, expression of syndecan-4 has been shown to be increased in the hypertrophic myocardium of mice after myocardial infarction [10] and in human aortic stenosis [11] , lack of syndecan-4 in mice has been shown to disturb and delay wound healing [12] . Hence, syndecan-4 is a good candidate for being a mechanosensor in cardiac fibroblasts.
NFAT signaling is established as a pathological signaling pathway in the development of cardiac hypertrophy [13] [14] [15] [16] . However, the role of syndecan-4 and NFAT signaling in cardiac fibroblasts has not been studied. Thus, the specific objective of this study was to examine if syndecan-4 signals via calcineurin/NFAT to regulate ECM production and myofibroblast differentiation of cardiac fibroblasts in response to mechanical stress.
Methods
A detailed methods section is included in the Online Supplement.
Mouse Model of Pressure Overload
Animals were handled according to the National Regulation on Animal Experimentation in accordance with the Norwegian Animal Welfare Act. The protocol was approved by the Norwegian National Animal Research Committee (permit of approval no. 2845). Initially, animals were anesthetized in a gas chamber containing 5% isoflurane and 95% oxygen where after the animals were intubated and ventilated with 2% isoflurane and 98% oxygen. Aortic banding (AB) was performed on eight week old male C57BL/6JBomTac mice (wild-type (WT); N=20) and syndecan-4 -/-mice [12] on a C57Bl/6J background (N=20) by placing a ligature distally around the ascending aorta as previously described [11] . Sham-operated animals underwent the same procedure without tightening the suture around the aorta. For post-operative analgesia, buprenorphine was injected subcutaneously. Animals with an aortic flow velocity >4 m/s, corresponding to a pressure gradient of more than 8.5 kPa, 24 hrs after AB as determined with echocardiography were included in the study. Animals were anesthetized (gas chamber with 5% isoflurane and 95% oxygen), decapitated and lungs and hearts dissected and weighed. In a separate set of mice (N=10), water content of the hearts was determined by drying the hearts at 60ºC for 24 hours and presented as relative amount of water ((wet weight-dry weight)/wet weight). Under non-stressed conditions, no phenotypic differences were observed between syndecan-4 -/-mice and WT mice.
Fibroblast Cell Culture
Neonatal (1-3 day old mice) mice were sacrificed by decapitation and left ventricles excised and cut into small pieces. Cardiac fibroblasts were freshly isolated as previously described [11] .
Primary cardiac fibroblasts from neonatal NFAT-luciferase [17] and syndecan-4 -/--NFAT-luciferase reporter mice [11] were used to determine NFAT activation and luminescence quantified according to the Luciferase Assay System protocol (E1500, Promega, Madison, WI). The human fibrosarcoma cell line HT1080 was purchased from ATCC (CCL-121, Manassas, VA). Cyclic stretch was applied to HT1080 or primary cardiac fibroblast cultures on collagen I-coated 6-well bioflex culture dishes at 1
Hz for 24 hrs using the FlexCell Tension System FX-4000 (Dunn Labortechnik, Asbach, Germany).
Cardiac and HT1080 fibroblasts were transfected with syndecan-4 or enhanced green fluorescent protein (EGFP)-fused NFATc1-4 using lipofectamine 2000 (Invitrogen, Paisley, UK) according to the manufacturer's protocol. Cyclosporine A (CsA, 1µmol/L; 586107, SandImmun Neoral, Novartis, Basel, Switzerland) was used for calcineurin inhibition. The NFAT blocker A-285222 was kindly provided by Abbott Laboratories (1µmol/L; Abbott Park, IL).
Gene Expression Analysis
mRNA was extracted from left ventricles and cell cultures using the RNeasy Mini Kit (Qiagen, Hilden, Germany). Reverse transcription of mRNA into cDNA was performed using the iScript cDNA Synthesis Kit (BIO-RAD, Hercules, CA) and real-time PCR performed using predesigned TaqMan assays (Applied Biosystems, Foster City, CA). Data were normalized to glyceraldehyde 3-phosphate dehydrogenase (GAPDH).
Immunoblotting
Immunoblotting was performed as described previously [18] . Protein from cell cultures and from homogenized left ventricles was harvested in a PBS-buffer containing 1% Triton X-100 (Sigma, Schnelldorf, Germany), 0.1% Tween 20 (Sigma) and protease inhibitors. SDS-PAGE and immunoblotting was performed essentially as described in the Criterion protocol (BIO-RAD).
Proximity Ligation Assay
Proximity ligation assays were performed using the Duolink kit from Olink Bioscience (Uppsala, Sweden) and primary antibodies toward syndecan-4 (1:50, custom made, Genscript, and 3644, BioVision, Milpitas, CA) and calcineurin A (1:50, sc-17808 and sc-6124, Santa Cruz Biotechnology). Incubation with syndecan-4 blocking peptide (3644BP, BioVision) was used as a negative control. Cells were fixed, permeabilized and incubated with the two primary antibodies overnight at 4°C and the proximity ligation assay performed according to the manufacturer's protocol and visualized using fluorescence microscopy.
Immunocytochemistry
Cells grown on fibronectin-coated glass cover slips were fixed and incubated with primary antibodies followed by incubation with alexa fluor 488-or 546-conjugated secondary antibodies (Invitrogen) , alexa fluor 546-phalloidin (Invitrogen) or sytox orange (Invitrogen) . Presence of wellorganized SMA fibers was determined for each cell. Mean intensity of SMA was determined using the analysis software from Zeiss (LSM 710) and normalized to the number of cells in each micrograph.
Statistics
Data are expressed as means ± S.E.M. Statistical analyses were performed using GraphPad software (Prism 5.04) and significance determined with one-way ANOVA for experiments with one intervention and two-way ANOVA with Bonferroni post-hoc testing for experiments with intervention in both WT and syndecan-4 -/-groups. Unpaired Student's t-test was used to test differences between two groups. ***P<0.005, **P<0.01, *P<0.05, n.s. non significant.
Results

Syndecan-4 is Important for the Differentiation of Cardiac Fibroblasts into Myofibroblasts in the Pressure-Overloaded Heart
Cardiac myofibroblasts exhibit enhanced production of ECM proteins when compared to fibroblasts [1] . Here we found that mRNA levels of collagen I, collagen III and fibronectin were significantly increased in the left ventricles of wild-type (WT) mice 24 hrs after AB, and that this upregulation was completely prevented for collagen I and III, and reduced for fibronectin in syndecan-4 -/-mice ( Figure 1A , B and C, respectively). mRNA levels of the myofibroblast-associated genes SMA and SM22 were also increased in the left ventricle of WT mice after AB, and this up-regulation was blunted in syndecan-4 -/-mice ( Figure 1D and E). We also examined the expression of another smooth muscle cell marker gene, smoothelin, which is generally not found in myofibroblasts [19, 20] .
Smoothelin mRNA was also increased after AB but this was not dependent on signaling through syndecan-4, since the same effects were observed in WT and syndecan-4 -/-mice ( Figure 1F ). AB resulted in a 3.6-fold up-regulation of syndecan-4 mRNA in WT left ventricular tissue ( Figure 1G ).
No changes in plasma levels of syndecan-4 were observed 24 hrs after AB. Syndecan-4 was equally expressed in neonatal cardiomyocytes and cardiac fibroblasts ( Figure 1H ). No significant differences were observed for any of the analyzed genes between sham WT and sham syndecan-4 -/-mice ( Figure   1 ). Body, heart and lung weight values for the studied animals (Supplemental Table S1 ) confirmed an effect of AB which resulted in increased left ventricular and lung weights, experimental signs of cardiac hypertrophy and congestive heart failure, respectively. The relative amount of water was unchanged following AB (sham: 75.6±0.1%; AB: 75.3±0.2%; n.s.). Taken together, our data suggests that syndecan-4 may be engaged in the stress response following pressure overload and plays a role in the regulation of ECM and myofibroblast marker genes.
Formation of Smooth Muscle α-Actin Fibers is Reduced in Syndecan-4 -/-and Cyclosporine ATreated Wild-Type Cardiac Fibroblasts In Vitro
Fibroblasts will spontaneously differentiate into myofibroblasts when cultured on a fibronectin-coated rigid substrate due to effects of fibronectin on focal adhesion assembly [21] and increased mechanical tension compared to the in vivo situation [22] . Fibroblasts stimulated with transforming growth factor β (TGFβ), a well-known inducer of SMA expression and myofibroblast differentiation, were used as a positive control, whereas exclusion of primary antibodies from the staining protocol was used as a negative control ( Figure 2E ).
Syndecan-4 and Calcineurin/NFAT Signaling are Involved in the Regulation of Collagen I and III Expression.
Increased expression of collagen I and III is characteristic of myofibroblast differentiation and central for the development of cardiac fibrosis. Along with the time-dependent changes in SMA expression and organization described above, cardiac fibroblasts from WT mice showed increasing levels of collagen I ( Figure 3A ) and III ( Figure 3C ) mRNA upon culture on fibronectin. In fibroblasts from syndecan-4 -/-mice, the expression of these collagens was lower and the effect of culture blunted.
Both CsA and the NFAT blocker A-285222 effectively prevented the induction of collagen I and III at 48 hrs indicating involvement of calcineurin and NFAT in the regulation of these genes ( Figure 3B and D). A parallel time-dependent increase in NFAT-dependent transcriptional activity was observed in cardiac fibroblasts from NFAT-luciferase reporter mice during culture, whereas NFAT activation was attenuated in fibroblasts from syndecan-4 -/--NFAT-luciferase reporter mice ( Figure 3E ).
Incubation with CsA or A-285222 significantly decreased NFAT-luciferase activity at 48 hrs ( Figure   3F ) showing the specificity of these blockers in cultured cardiac fibroblasts. Hence, our data demonstrate that signaling via syndecan-4, calcineurin and NFAT is involved in the regulation of collagen I and III during myofibroblast differentiation. The reduced myofibroblast differentiation observed in syndecan-4 -/-cardiac fibroblasts did not appear to be due to reduced TGFβ expression, since TGFβ mRNA levels were similar in WT and syndecan-4 -/-at all time points (Supplemental Figure S2 ).
NFATc4 is Activated in a Syndecan-4-Dependent Manner in Response to Mechanical Stress
The NFAT-luciferase reporter system does not discriminate between NFATc isoforms. We therefore used NFATc1-c4-EGFP fusion proteins to determine isoform-specific activation. For sufficient transfection, we used HT1080 fibroblasts for these experiments. As this cell line did not spontaneously differentiate into myofibroblasts on fibronectin after 48 hrs, we subjected the cells to mechanical stress by applying cyclic stretch for 24 hrs. This significantly increased the amount of the well-established early myofibroblast marker, extradomain A (EDA) of fibronectin [23] (Figure 4A) indicating myofibroblast differentiation in this model. TGFβ-stimulation was used as positive control for myofibroblast differentiation ( Figure 4A ). We then quantified nuclear accumulation of NFAT fusion proteins as a measure for activation following mechanical stress. NFATc1-EGFP and NFATc3-EGFP were already predominantly nuclear under control non-stimulated conditions. NFATc2-EGFP showed a tendency to translocate to the nucleus following stretch, whereas NFATc4-EGFP was predominantly cytosolic under control conditions and clearly accumulated in the nucleus after 24 hrs of cyclic stretch ( Figure 4B ). Despite lower transfection efficiency, corresponding experiments were carried out in primary cardiac fibroblasts, demonstrating significantly increased NFATc4-EGFP nuclear accumulation following cyclic stretch ( Figure 4B , right panel).
To investigate if stretch could activate endogenous NFATc4 in primary cardiac fibroblasts and whether activation required syndecan-4, we compared the levels of inactive phosphorylated NFATc4 in WT and syndecan-4 -/-fibroblasts following 24 hrs of cyclic stretch. To avoid the effect of fibronectin on fibroblast phenotype and isolate the effect of stretch per se, membranes were coated with collagen I in these experiments. NFATc4 phosphorylation was reduced following stretch in cardiac fibroblasts from WT mice reflecting increased activation of NFATc4, whereas phosphorylation levels were not significantly affected in fibroblasts from syndecan-4 -/-mice ( Figure   4C ), suggesting involvement of syndecan-4 in stretch-induced NFATc4 activation. Furthermore, the stretch-induced dephosphorylation of NFATc4 was prevented by CsA ( Figure 4D ) indicating calcineurin-dependence in this response. Expression levels of NFATc4 mRNA were unchanged in cardiac fibroblasts from WT mice (ctrl 1.0±0.3, ms 0.7±0.2) and syndecan-4 -/-mice (ctrl 1.0±0.1, ms 0.8±0.2) following stretch (N=10). Hence, the observed changes in the levels of phosphorylated NFATc4 proteins are less likely due to changes in total NFATc4 expression. Over-expression of syndecan-4 in HT1080 fibroblasts lead to dephosphorylation of NFATc4 ( Figure 4E ), again supporting a role for syndecan-4 in NFATc4 activation.
Regulator of calcineurin 1.4 (RCAN1.4) is a well-established NFAT-target in the heart [24, 25] as well as in various vascular tissues [26] . Indeed, RCAN1.4 was up-regulated upon overexpression of calcineurin or NFATc4 (Supplemental Figure S3A and B), showing that RCAN1.4 can function as a readout for calcineurin-NFAT activation in fibroblasts. We also found that overexpressing syndecan-4, which readily activates NFATc4 (see previous paragraph and Figure 4E ), resulted in significantly up-regulated RCAN1.4 expression both in HT1080 fibroblasts and in primary cardiac fibroblasts (Supplemental Figure S3C and D) . Altogether these data support that a transcriptionally functional pathway is in place in these cells and that it engages syndecan-4, calcineurin and NFATc4.
Syndecan-4 and Calcineurin Co-localize in Cardiac Fibroblasts
Based on the results showing that syndecan-4 and calcineurin regulate stretch-induced activation of NFATc4, we wished to determine whether syndecan-4 and calcineurin located close enough to each other to physically interact in cardiac fibroblasts. For these experiments we used syndecan-4 antibodies directed towards epitopes of the intracellular domain of the protein [11] .
Syndecan-4 and calcineurin were indeed found to co-localize in cardiac fibroblasts (<40 nm apart) as determined by a proximity ligation assay ( Figure 5A ), substantiating a potential interaction between these proteins. No signal was observed in assays performed with syndecan-4 blocking peptide or on cardiac fibroblasts from syndecan-4 -/-mice. In agreement with these results, syndecan-4 has been found by us to co-immunoprecipitate with calcineurin in mouse left ventricles in vivo, and to bind directly to calcineurin in vitro [11] . In that study, the binding region was located to the autoinhibitory domain of calcineurin, suggesting that calcineurin may be activated upon binding to syndecan-4.
Hence, syndecan-4 and calcineurin could comprise a mechanosignaling complex at focal adhesions in cardiac fibroblasts causing NFATc4 activation following mechanical stress. In line with previous work [21, [27] [28] [29] , vinculin confocal immunofluorescence revealed fewer and smaller focal adhesions in fibroblasts from syndecan-4 -/-mice when compared to those from WT mice (Supplemental Figure S4) which may imply impaired focal adhesion signaling in cardiac fibroblasts from syndecan-4 -/-mice.
Syndecan-4 Phosphorylation at Serine179 is Reduced in Cardiac Fibroblasts Following
Mechanical Stress
We next searched for a mechanism that could explain syndecan-4-mediated activation of NFAT in response to mechanical stress. A previous study in our group had indicated that phosphorylation of serine179 (pS179) in the cytoplasmic part of syndecan-4 negatively regulated the syndecan-4-calcineurin interaction in mouse left ventricles [11] . Thus, we used HT1080 fibroblasts over-expressing syndecan-4 to investigate whether mechanical stress regulated pS179. Firstly, colocalization of calcineurin and syndecan-4 was also observed in this cell system ( Figure 5B ).
Secondly, 24 hrs of stretch caused a 44% reduction in pS179 ( Figure 5C ), suggesting that syndecan-4 dephosphorylation might be a stretch-induced molecular switch causing NFATc4 activation via calcineurin in fibroblasts.
Over-expression of NFATc4 Enhances the Expression of Collagen III and MyocardinRelated Transcription Factor A
To determine whether increased expression of NFATc4 per se could affect the expression of myofibroblast-associated genes, we examined the effect of NFATc4 over-expression. Due to low transfection efficiency of primary cardiac fibroblasts, HT1080 fibroblasts were used for this purpose.
Expression levels of NFATc4 were increased 48 hrs after transfection at which point collagen I mRNA was unchanged ( Figure 6A ), but collagen III was markedly up-regulated ( Figure 6B) supporting a role for NFATc4 in the regulation of this gene. No difference was found in SMA mRNA ( Figure 6C ) but interestingly, myocardin-related transcription factor A (MRTF-A) mRNA levels were significantly increased when compared to control cells ( Figure 6D ). MRTF-A is a well-known regulator of SMA gene expression [30] and has recently been associated with myofibroblast differentiation [31] .
Discussion
This study demonstrates that syndecan-4 is important for extracellular matrix production and differentiation of cardiac fibroblasts into myofibroblasts in the pressure-overloaded heart in vivo and in response to mechanical stress in vitro. We also show that the calcineurin/NFATc4 signaling pathway is engaged upon mechanical stress in a syndecan-4-dependent manner and that once activated, it plays a role in myofibroblast differentiation and the production of extracellular matrix.
This is based on the following findings: 1) Myofibroblast differentiation was impaired in syndecan-4 Fibroblasts are the most abundant cells in the myocardium and display considerable plasticity allowing them to adjust to extracellular cues such as mechanical stress. Even though in vivo data from tissue homogenates presented in this study do not allow a complete distinction of the cell types contributing to the pressure-induced responses, it is generally accepted that fibroblasts are responsible for ECM production and hence cause the increase in collagen I and collagen III observed after AB.
This effect was clearly altered in the syndecan-4 -/-animals and would be predicted to translate into reduced fibrosis following long-term pressure overload in these mice. It is important to highlight though that pressure overload likely affects multiple pathways simultaneously and that the complete lack of syndecan-4 may have an impact on these pathways, hampering the interpretation of the in vivo results. However, the in vitro results from the study are in line with the in vivo data. The in vitro conditions used here expose cells to increased mechanical tension compared to the in vivo situation in a healthy heart, and thus recreate several aspects of myofibroblast differentiation as it occurs in vivo after AB, not only by increasing the expression of ECM gene transcripts, but also by induction of contractile proteins and formation of organized SMA fibers.
Myofibroblast differentiation in response to mechanical stress was found to be dependent on signaling via syndecan-4. Previous work from our group demonstrated increased expression of syndecan-4 in the hypertrophic myocardium of mice after myocardial infarction [10] and in human aortic stenosis [11] . Here we show that the same is true in the pressure-overloaded heart of mice after AB. Along these lines, serum syndecan-4 has recently been proposed as a novel diagnostic and prognostic biomarker for patients with heart failure [32] . Plasma syndecan-4 levels were not changed after AB in our study, but it may take longer than 24 hours for the changes to occur. Expression levels of syndecan-4 were similar in cardiomyocytes and fibroblasts, suggesting that both cell types may be contributing to the expression levels measured in heart homogenates. While our previous study clearly established that syndecan-4 in cardiac myocytes is essential for compensatory hypertrophy in the pressure-overloaded heart [11] , we here show that this transmembrane proteoglycan also plays a role in a parallel process that is taking place in cardiac fibroblasts in response to the increased pressure.
Findings by Matsui et al. also support a role for syndecan-4 in this process, since they found impaired myofibroblast differentiation in the infarcted region after coronary ligation in syndecan-4 -/-mice [33] .
However, the signaling mechanism was not examined.
In our study, myofibroblast differentiation was found to be dependent on calcineurin signaling.
Vast evidence substantiates the role of calcineurin/NFAT in ventricular cardiomyocytes in hypertrophy [14, 34] , and in vivo studies using genetically modified mice demonstrated a necessary role for NFATc2 [16] , NFATc3 [15] and NFATc4 [14] as downstream effectors of calcineurin.
However, the role of calcineurin/NFAT signaling in cardiac fibroblasts is poorly defined. Calcineurin has been indirectly implicated in the development of cardiac fibrosis [14, 34, 35] , and transgenic mice expressing constitutively active calcineurin in cardiomyocytes not only developed cardiac hypertrophy, but a concomitant accumulation of collagen deposits surrounding the degenerating cardiomyocytes [14, 34] . Also, in vivo treatment with pharmacological inhibitors of calcineurin could limit the pressure overload-induced cardiac fibrosis [34] . We now provide direct evidence for a role of calcineurin/NFAT signaling in collagen production in cardiac fibroblasts. Our data show that similarly to cardiomyocytes [18] , NFATc4 is engaged in response to mechanical stress in cardiac fibroblasts.
NFATc1 and NFATc3 were not sensitive to applied mechanical stress, but at the moment we cannot rule out a possible contribution of NFATc2 to myofibroblast differentiation, given the observed tendency to increased activation. Reduced fibrosis has indeed been described in pressure-overloaded left ventricles of NFATc2 knockout mice when compared to those of WT mice [16] . Whether this was due to lack of NFATc2 in cardiomyocytes or in fibroblasts or in both remained unresolved.
The increased NFAT-dependent transcriptional activity measured during myofibroblast differentiation lead to increased collagen I and III mRNA. NFAT involvement in the regulation of collagen I has been shown in osteoblasts and in tendon fibroblasts [36, 37] but, to our knowledge, the here suggested role for NFAT as regulator of collagen III is new. In our hands, NFATc4 overexpression per se did not increase collagen I mRNA levels. One possible interpretation of these results is that collagen I expression could be driven instead by another NFAT isoform, such as NFATc2.
Alternatively, collagen I transcription may require cooperation with additional transcription factors (an important feature of NFAT transcription factors) that are either not expressed in the HT1080 fibroblasts or not activated under these experimental conditions (where syndecan-4 and mechanical stress is bypassed). The exact identity of these partners remains to be elucidated, but exciting work recently published from the Molkentin's lab describes a direct and functional interaction between NFAT and NFκB, critical for cardiac hypertrophy and remodeling [38] . Even though most of the data supporting this interaction is from cardiomyocytes, interaction was also observed in mouse embryonic fibroblasts.
Several intracellular signaling pathways and molecules have previously been implicated in myofibroblast differentiation, one of the most important being the transcription partners serum response factor (SRF) and myocardin-related transcription factors A and B (MRTF-A and B) [39] .
These bind to specific elements in the SMA promoter and other myofibroblast marker genes thereby regulating transcription [30] . The means whereby mechanical stress induces myofibroblast differentiation are still unknown. One possibility is the engagement of MRTF-A which translocates to the nucleus in response to mechanical stress in a Rho kinase-dependent manner [39, 40] and has also been shown to cause myofibroblast marker gene expression in cardiac fibroblasts [41] . Interestingly, RhoA activity (which in turn activates Rho kinase) is reduced in cardiac fibroblasts from syndecan-4 -/-mice [33] . Furthermore, NFATc4 over-expression resulted in increased MRTF-A mRNA, which may in turn promote myofibroblast differentiation [31] . Hence, syndecan-4 may influence myofibroblast differentiation by regulating not only the expression of MRTF-A (via NFATc4) but also the activation of MRTF-A (via RhoA).
Cardiac fibrosis is a characteristic of several heart diseases including myocardial infarction and hypertrophy, and involves excessive synthesis of ECM proteins such as the collagens [42] . This increases myocardial stiffness and contributes to ventricular diastolic dysfunction which has lately been found to account for a larger proportion of heart failure patients than previously suspected. To date, there is no effective treatment for cardiac fibrosis, which remains a challenging area in clinical practice. There have been attempts to interfere with myofibroblast formation by targeting TGF-signaling in fibrotic tissues [43, 44] . TGF is a potent inducer of myofibroblast differentiation, but it has a wide range of effects on cardiomyocytes, mesenchymal and immune cells [45] . Drugs targeting other circulating hormones and growth factors implicated in this pathology (i.e. endothelin-1, angiotensin II, connective tissue growth factor, platelet-derived growth factor) are currently under consideration [46] . However, due to their pleiotropic and multifunctional effects total blockade of these signaling molecules may not be without side-effects. A need for more specific targets is clear.
We found that syndecan-4 is involved in myofibroblast differentiation of cardiac fibroblasts in the left ventricle in response to pressure overload and in mechanically stressed cardiac fibroblasts in vitro.
Syndecan-4 engages the calcineurin/NFAT signaling pathway in cardiac fibroblasts subjected to 
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SUPPLEMENTAL MATERIAL Detailed Methods
Mouse Model of Pressure Overload
Initially, animals were anesthetized in a gas chamber containing 5% isoflurane and 95% oxygen where after the animals were intubated and ventilated with 2% isoflurane and 98% oxygen. Aortic banding (AB) or sham operation was performed on eight week old male C57BL/6JBomTac mice (N=20;
Taconic, Skensved, Denmark) and syndecan-4 -/-mice [1] on a C57Bl/6J background (N=20; 000664,
The Jackson Laboratory, Bar Harbor, ME) as previously described [2] . Sham-operated animals underwent the same procedure without tightening the suture around the aorta. For post-operative analgesia, buprenorphine was injected subcutaneously. To ensure successful AB and rule out total occlusure, flow velocity across the aorta was determined with echocardiography 24 hrs after AB.
Animals with an aortic flow velocity>4 m/s after AB were included in the study. Animals were anesthetized (gas chamber with 5% isoflurane and 95% oxygen), decapitated and lungs and hearts dissected and weighed.
Syndecan-4 ELISA
Blood was withdrawn and separated into serum and plasma. Plasma syndecan-4 was determined by ELISA (E03S0065, Blue Gene Biotech, Shanghai, China).
Fibroblast Cell Culture
Cardiac fibroblasts from 1-3 day old mice were freshly isolated as previously described. [2] Mice where sacrificed by decapitation and left ventricles excised and cut into small pieces. After digestion with collegenase, the suspension was transferred to 150cm 2 flasks and incubated at 37ºC in 5% CO 2 so that cardiac fibroblasts attached to the flask whereas the suspension containing cardiomyocytes could be removed. The second passage of cells was used to minimize in vitro effects on fibroblast phenotype. The human fibrosarcoma cell line HT1080 was purchased from ATCC (CCL-121,
Supplemental Results
Expression of ECM Remodeling Proteins and Migration of Cardiac Fibroblasts.
The pattern of expression of several proteins involved in ECM remodeling was changed in parallel to myofibroblast differentiation and differentially affected by the genotype of the mice (Supplemental Figure S5A ). Expression levels of matrix metalloproteinase (MMP) 13 and tissue inhibitor of metalloproteinase 1 (TIMP1) were higher in cardiac fibroblasts from syndecan-4 -/-mice when compared to fibroblasts from WT mice, whereas MMP9 levels were lower (Supplemental Figure   S5A ). MMP13 and TIMP1 are known to enhance migration of several cell types [5] [6] [7] , whereas MMP9 has the opposite effect [7] . In agreement with this, we found increased migration in fibroblasts from syndecan-4 -/-mice when compared to those from WT mice (Supplemental Figure S5B ). As demonstrated in Supplemental Figure S4 and in line with previous work [8] [9] [10] [11] , vinculin confocal immunofluorescence revealed fewer and smaller focal adhesions in fibroblasts from syndecan-4 -/-mice. This may also enhance migration in syndecan-4 -/-cardiac fibroblasts as binding strength to the substrate will be reduced. 
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